During the past decade, Cardiovascular Consultants conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Consultants" #1 sponsor was "Point Biomedical" with 5 trials, followed by "Lantheus Medical Imaging" with 2 trials sponsored, "Aspire Foundation" with 1 trials sponsored, "Cardiovascular Imaging Technologies" with 1 trials sponsored and "Shockwave Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Consultants" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Blue Cross Blue Shield" with 1 trials as a collaborator, "Cardiovascular Imaging Technologies" with 1 trials as a collaborator, "Mid America Heart Institute" with 1 trials as a collaborator and "Saint Luke's Cardiovascular Consultants" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Consultants" are "Coronary Artery Disease" (7 trials), "Healthy" (1 trials), "Ischemia" (1 trials), "Peripheral Arterial Disease" (1 trials) and "Pulmonary Heart Disease" (1 trials). Many other conditions were trialed in "Cardiovascular Consultants" in a lesser frequency.

Most popular intervention types in "Cardiovascular Consultants" are "Drug" (8 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "PB127 for Injectable Suspension" (2 trials), "PB127 for injectable suspension" (2 trials), "BMS747158" (1 trials), "Definity" (1 trials) and "Medtronic IN.PACT (DCB)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Consultants" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cardiovascular Consultants, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Consultants, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".